-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_SEVERITY.PDF
January 01, 2002 - AMI, HEART FAILURE OR SHOCK 29233 0.37
173: OTHER VASCULAR PROCEDURES 37312 0.48
174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 45905 0.58
175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 106748 1.36
176: CARDIAC … PROCS W/O CC 5244 0.07
1101: MAJOR CARDIOVASCULAR PROCS W CC 10964 0.14
1102: MAJOR CARDIOVASCULAR … System 258 0.00
CVS81: Neoplasm, Malignant, Cardiovascular 40 0.00
CVS82: Other Atherosclerosis 10880 … 0.14
CVS83: Other Cardiac Conditions 3777 0.05
CVS84: Other Cardiovascular Symptoms 4234 0.05
CVS85
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2002 - AMI, HEART FAILURE OR SHOCK 3000 0.38
173: OTHER VASCULAR PROCEDURES 3695 0.47
174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 4681 0.60
175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 10672 1.36
176: CARDIAC … PROCS W/O CC 529 0.07
1101: MAJOR CARDIOVASCULAR PROCS W CC 1127 0.14
1102: MAJOR CARDIOVASCULAR PROCS … System 22 0.00
CVS81: Neoplasm, Malignant, Cardiovascular <= 10 **.**
CVS82: Other Atherosclerosis … 1097 0.14
CVS83: Other Cardiac Conditions 374 0.05
CVS84: Other Cardiovascular Symptoms 443 0.06
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2002 - AMI, HEART FAILURE OR SHOCK 3017 0.38
173: OTHER VASCULAR PROCEDURES 3789 0.48
174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 4514 0.57
175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 10828 1.38
176: CARDIAC … PROCS W/O CC 515 0.07
1101: MAJOR CARDIOVASCULAR PROCS W CC 1075 0.14
please refer to the section … System 37 0.00
CVS81: Neoplasm, Malignant, Cardiovascular <= 10 **.**
CVS82: Other Atherosclerosis … 1106 0.14
CVS83: Other Cardiac Conditions 377 0.05
CVS84: Other Cardiovascular Symptoms 421 0.05
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2004 - AMI, HEART FAILURE OR SHOCK 3002 0.38
173: OTHER VASCULAR PROCEDURES 4349 0.54
174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI 4898 0.61
175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 11640 1.45
176: CARDIAC … PROCS W/O CC 582 0.07
1101: MAJOR CARDIOVASCULAR PROCS W CC 1159 0.14
1102: MAJOR CARDIOVASCULAR PROCS … System 19 0.00
CVS81: Neoplasm, Malignant, Cardiovascular <= 10 **.**
CVS82: Other Atherosclerosis … 1110 0.14
CVS83: Other Cardiac Conditions 392 0.05
CVS84: Other Cardiovascular Symptoms 444 0.06
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2003_SummaryStats_SEVERITY.PDF
January 01, 2003 - O AMI, HEART FAILURE OR SHOCK 505 0.02
173: OTHER VASCULAR PROCEDURES 2756 0.09
174: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W AMI <= 10 **.**
175: PERCUTANEOUS CARDIOVASCULAR PROCEDURES W/O AMI 1726 0.06
176: CARDIAC … PROCS W/O CC 1088 0.04
1101: MAJOR CARDIOVASCULAR PROCS W CC 2002 0.07
1102: MAJOR CARDIOVASCULAR … System 28 0.00
CVS81: Neoplasm, Malignant, Cardiovascular <= 10 **.**
CVS82: Other Atherosclerosis … 3188 0.11
CVS83: Other Cardiac Conditions 862 0.03
CVS84: Other Cardiovascular Symptoms 889 0.03
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
June 01, 2015 - circumference
of more than 37 inches in men and 31.5 inches in women is associated with increased
cardiovascular … Other approval conditions included multiple postmarketing studies to
evaluate cardiovascular outcomes … Cardiovascular events were not statistically different with liraglutide and placebo (8.7% vs. 9.9%, … The company is also conducting a cardiovascular outcomes trial.31,56 FDA
had approved liraglutide injection … Studies better
defining the potential long-term risks (breast cancer and cardiovascular risks) need
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V23%20Definitions%20Manual.pdf
August 01, 2006 - If yes, check for the presence of a “major cardiovascular condition” as
defined by the CMS v23.0 DRG … If a “major cardiovascular condition” is present, set the DRG = 553. … If a “major cardiovascular condition” is not present, set the DRG = 554.
Proceed to Step 13.
11. … CATH
108 108 OTHER CARDIOTHORACIC PROCEDURES
109 109 CORONARY BYPASS W/O CARDIAC CATH
110 110 MAJOR CARDIOVASCULAR … PROCS
111 110 MAJOR CARDIOVASCULAR PROCS
113 113 AMPUT FOR CIRC DISOR EXC UPPR LIMB & TOE
114 114
-
psnet.ahrq.gov/node/867206/psn-pdf
December 18, 2024 - Descriptive term Usual diagnostic implication
Vertigo Implies an inner ear cause
Lightheadedness Implies a cardiovascular … Furthermore, patients with BPPV often
complain of non-specific dizziness,3 and some patients with cardiovascular … How often is dizziness from primary cardiovascular
disease true vertigo? A systematic review.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - metabolic and microvessel
alterations as a result of chronic hyperglycemia exposure (diabetes) and cardiovascular … nausea
o Neuropsychiatric effects (ONLY for smoking cessation studies involving
pharmacotherapy)
o Cardiovascular … severe and total)
Gastrointestinal side effects,
including nausea,
Neuropsychiatric effects*,
Cardiovascular
-
www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/hisph-slides-pt4.html
March 01, 2020 - New Mexico and Texas are weak in care for cardiovascular disease. … Arizona is also strong in care for cardiovascular disease. … Cardiovascular: Any Dx in CCS 96-109.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
January 01, 2023 - Efficacy of Dental Services for Reducing Adverse
Events in Those Undergoing Insertion of Implantable
Cardiovascular … Efficacy of Dental Services for Reducing Adverse Events in Those Undergoing Insertion of Implantable
Cardiovascular … The Relationship of Digestible Carbohydrate Intake With Cardiovascular Disease
44.
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
January 01, 2012 - heart failure or shock 22,520 0.31%
173: Other vascular procedures 43,579 0.60%
174: Percutaneous cardiovascular … procedures w AMI 55,140 0.76%
175: Percutaneous cardiovascular procedures w/o AMI 61,111 0.84%
please … -2499g, normal newborn or neonate w other problem 21,624 0.30%
630: Neonate birthwt >2499g w major cardiovascular
-
www.ahrq.gov/sites/default/files/2025-03/rinke-report.pdf
January 01, 2025 - important, as
pre-hypertensive children are at greater risk for developing hypertension and have worse
cardiovascular … Expert panel on integrated guidelines for cardiovascular health and risk reduction in
children and adolescents … Defining and setting national goals for
cardiovascular health promotion and disease reduction: the American
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
January 01, 2014 - heart failure or shock 46,293 0.31%
173: Other vascular procedures 94,486 0.63%
174: Percutaneous cardiovascular … procedures w AMI 124,245 0.83%
175: Percutaneous cardiovascular procedures w/o AMI 110,155 0.74% … -2499g, normal newborn or neonate w other problem 23,207 0.16%
630: Neonate birthwt >2499g w major cardiovascular
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
October 31, 2017 - heart failure or shock 40,248 0.31%
173: Other vascular procedures 82,192 0.64%
174: Percutaneous cardiovascular … procedures w AMI 111,313 0.86%
175: Percutaneous cardiovascular procedures w/o AMI 95,800 0.74% … -2499g, normal newborn or neonate w other problem 19,146 0.15%
630: Neonate birthwt >2499g w major cardiovascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb233-Operating-Room-Procedures-United-States-2014.pdf
January 01, 2014 - Three cardiovascular procedures—percutaneous
coronary angioplasty, coronary artery bypass graft, and … ■ Musculoskeletal and cardiovascular procedures were most common among older patients in
2014. … Costs associated with four cardiovascular procedures— percutaneous coronary angioplasty, coronary
artery
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Hougland_26.pdf
October 01, 2011 - Poisoning by agents
primarily affecting the
cardiovascular system Total % 90.0 –
Inpatient 13/153 … Adverse effects of agents
primarily affecting the
cardiovascular system Total % 67.4 81.5
Inpatient … depressants,
stimulants, and anesthetics (13 percent); and poisoning by agents primarily affecting the
cardiovascular
-
psnet.ahrq.gov/sites/default/files/2021-05/final_psnet_spotlight_inadvertent_bolus_of_norepinephrine_pp.pdf
January 01, 2021 - The Journal of thoracic and cardiovascular surgery.
1998 Dec 1;116(6):973-80.
3. … Vasoplegia after cardiovascular procedures—pathophysiology and
targeted therapy.
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/LomotanDougherty2013.pdf
April 01, 2013 - Expert Panel on Integrated Guidelines for Cardiovascular Health
and Risk Reduction in Children and Adolescents … Expert panel on integrated guidelines for
cardiovascular health and risk reduction in children and adoles
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/care-coordination-implementation-guide.pdf
March 01, 2023 - Enhancing Care Coordination for CR
Acronym List
Term Abbreviation
AACVPR American Association of Cardiovascular … to participate in CR was developed by the Joint
International Council and Canadian Association of Cardiovascular